1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Multi-Infarct Dementia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Pharmacological Treatment 1.2.3 Non Pharmacological Treatment 1.3 Market by Application 1.3.1 Global Multi-Infarct Dementia Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Academic 1.3.3 Hospitals 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Multi-Infarct Dementia Market Perspective (2016-2027) 2.2 Multi-Infarct Dementia Growth Trends by Regions 2.2.1 Multi-Infarct Dementia Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Multi-Infarct Dementia Historic Market Share by Regions (2016-2021) 2.2.3 Multi-Infarct Dementia Forecasted Market Size by Regions (2022-2027) 2.3 Multi-Infarct Dementia Industry Dynamic 2.3.1 Multi-Infarct Dementia Market Trends 2.3.2 Multi-Infarct Dementia Market Drivers 2.3.3 Multi-Infarct Dementia Market Challenges 2.3.4 Multi-Infarct Dementia Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Multi-Infarct Dementia Players by Revenue 3.1.1 Global Top Multi-Infarct Dementia Players by Revenue (2016-2021) 3.1.2 Global Multi-Infarct Dementia Revenue Market Share by Players (2016-2021) 3.2 Global Multi-Infarct Dementia Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Multi-Infarct Dementia Revenue 3.4 Global Multi-Infarct Dementia Market Concentration Ratio 3.4.1 Global Multi-Infarct Dementia Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Multi-Infarct Dementia Revenue in 2020 3.5 Multi-Infarct Dementia Key Players Head office and Area Served 3.6 Key Players Multi-Infarct Dementia Product Solution and Service 3.7 Date of Enter into Multi-Infarct Dementia Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Multi-Infarct Dementia Breakdown Data by Type 4.1 Global Multi-Infarct Dementia Historic Market Size by Type (2016-2021) 4.2 Global Multi-Infarct Dementia Forecasted Market Size by Type (2022-2027) 5 Multi-Infarct Dementia Breakdown Data by Application 5.1 Global Multi-Infarct Dementia Historic Market Size by Application (2016-2021) 5.2 Global Multi-Infarct Dementia Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Multi-Infarct Dementia Market Size (2016-2027) 6.2 North America Multi-Infarct Dementia Market Size by Type 6.2.1 North America Multi-Infarct Dementia Market Size by Type (2016-2021) 6.2.2 North America Multi-Infarct Dementia Market Size by Type (2022-2027) 6.2.3 North America Multi-Infarct Dementia Market Size by Type (2016-2027) 6.3 North America Multi-Infarct Dementia Market Size by Application 6.3.1 North America Multi-Infarct Dementia Market Size by Application (2016-2021) 6.3.2 North America Multi-Infarct Dementia Market Size by Application (2022-2027) 6.3.3 North America Multi-Infarct Dementia Market Size by Application (2016-2027) 6.4 North America Multi-Infarct Dementia Market Size by Country 6.4.1 North America Multi-Infarct Dementia Market Size by Country (2016-2021) 6.4.2 North America Multi-Infarct Dementia Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Multi-Infarct Dementia Market Size (2016-2027) 7.2 Europe Multi-Infarct Dementia Market Size by Type 7.2.1 Europe Multi-Infarct Dementia Market Size by Type (2016-2021) 7.2.2 Europe Multi-Infarct Dementia Market Size by Type (2022-2027) 7.2.3 Europe Multi-Infarct Dementia Market Size by Type (2016-2027) 7.3 Europe Multi-Infarct Dementia Market Size by Application 7.3.1 Europe Multi-Infarct Dementia Market Size by Application (2016-2021) 7.3.2 Europe Multi-Infarct Dementia Market Size by Application (2022-2027) 7.3.3 Europe Multi-Infarct Dementia Market Size by Application (2016-2027) 7.4 Europe Multi-Infarct Dementia Market Size by Country 7.4.1 Europe Multi-Infarct Dementia Market Size by Country (2016-2021) 7.4.2 Europe Multi-Infarct Dementia Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Multi-Infarct Dementia Market Size (2016-2027) 8.2 Asia-Pacific Multi-Infarct Dementia Market Size by Type 8.2.1 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2027) 8.3 Asia-Pacific Multi-Infarct Dementia Market Size by Application 8.3.1 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2027) 8.4 Asia-Pacific Multi-Infarct Dementia Market Size by Region 8.4.1 Asia-Pacific Multi-Infarct Dementia Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Multi-Infarct Dementia Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Multi-Infarct Dementia Market Size (2016-2027) 9.2 Latin America Multi-Infarct Dementia Market Size by Type 9.2.1 Latin America Multi-Infarct Dementia Market Size by Type (2016-2021) 9.2.2 Latin America Multi-Infarct Dementia Market Size by Type (2022-2027) 9.2.3 Latin America Multi-Infarct Dementia Market Size by Type (2016-2027) 9.3 Latin America Multi-Infarct Dementia Market Size by Application 9.3.1 Latin America Multi-Infarct Dementia Market Size by Application (2016-2021) 9.3.2 Latin America Multi-Infarct Dementia Market Size by Application (2022-2027) 9.3.3 Latin America Multi-Infarct Dementia Market Size by Application (2016-2027) 9.4 Latin America Multi-Infarct Dementia Market Size by Country 9.4.1 Latin America Multi-Infarct Dementia Market Size by Country (2016-2021) 9.4.2 Latin America Multi-Infarct Dementia Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Multi-Infarct Dementia Market Size (2016-2027) 10.2 Middle East & Africa Multi-Infarct Dementia Market Size by Type 10.2.1 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2027) 10.3 Middle East & Africa Multi-Infarct Dementia Market Size by Application 10.3.1 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2027) 10.4 Middle East & Africa Multi-Infarct Dementia Market Size by Country 10.4.1 Middle East & Africa Multi-Infarct Dementia Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Multi-Infarct Dementia Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Forest Laboratories 11.1.1 Forest Laboratories Company Details 11.1.2 Forest Laboratories Business Overview 11.1.3 Forest Laboratories Multi-Infarct Dementia Introduction 11.1.4 Forest Laboratories Revenue in Multi-Infarct Dementia Business (2016-2021) 11.1.5 Forest Laboratories Recent Development 11.2 Janssen Pharmaceuticals 11.2.1 Janssen Pharmaceuticals Company Details 11.2.2 Janssen Pharmaceuticals Business Overview 11.2.3 Janssen Pharmaceuticals Multi-Infarct Dementia Introduction 11.2.4 Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) 11.2.5 Janssen Pharmaceuticals Recent Development 11.3 Novartis Pharmaceutical 11.3.1 Novartis Pharmaceutical Company Details 11.3.2 Novartis Pharmaceutical Business Overview 11.3.3 Novartis Pharmaceutical Multi-Infarct Dementia Introduction 11.3.4 Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) 11.3.5 Novartis Pharmaceutical Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Multi-Infarct Dementia Introduction 11.4.4 Pfizer Revenue in Multi-Infarct Dementia Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Eisai 11.5.1 Eisai Company Details 11.5.2 Eisai Business Overview 11.5.3 Eisai Multi-Infarct Dementia Introduction 11.5.4 Eisai Revenue in Multi-Infarct Dementia Business (2016-2021) 11.5.5 Eisai Recent Development 11.6 Ortho-McNeil Pharmaceutical 11.6.1 Ortho-McNeil Pharmaceutical Company Details 11.6.2 Ortho-McNeil Pharmaceutical Business Overview 11.6.3 Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Introduction 11.6.4 Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) 11.6.5 Ortho-McNeil Pharmaceutical Recent Development 11.7 Takeda 11.7.1 Takeda Company Details 11.7.2 Takeda Business Overview 11.7.3 Takeda Multi-Infarct Dementia Introduction 11.7.4 Takeda Revenue in Multi-Infarct Dementia Business (2016-2021) 11.7.5 Takeda Recent Development 11.8 Jubilant Cadista Pharmaceuticals 11.8.1 Jubilant Cadista Pharmaceuticals Company Details 11.8.2 Jubilant Cadista Pharmaceuticals Business Overview 11.8.3 Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Introduction 11.8.4 Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) 11.8.5 Jubilant Cadista Pharmaceuticals Recent Development 11.9 Takeda Pharmaceutical 11.9.1 Takeda Pharmaceutical Company Details 11.9.2 Takeda Pharmaceutical Business Overview 11.9.3 Takeda Pharmaceutical Multi-Infarct Dementia Introduction 11.9.4 Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) 11.9.5 Takeda Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Multi-Infarct Dementia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Pharmacological Treatment Table 3. Key Players of Non Pharmacological Treatment Table 4. Global Multi-Infarct Dementia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Multi-Infarct Dementia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Multi-Infarct Dementia Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Multi-Infarct Dementia Market Share by Regions (2016-2021) Table 8. Global Multi-Infarct Dementia Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Multi-Infarct Dementia Market Share by Regions (2022-2027) Table 10. Multi-Infarct Dementia Market Trends Table 11. Multi-Infarct Dementia Market Drivers Table 12. Multi-Infarct Dementia Market Challenges Table 13. Multi-Infarct Dementia Market Restraints Table 14. Global Multi-Infarct Dementia Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Multi-Infarct Dementia Market Share by Players (2016-2021) Table 16. Global Top Multi-Infarct Dementia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multi-Infarct Dementia as of 2020) Table 17. Ranking of Global Top Multi-Infarct Dementia Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Multi-Infarct Dementia Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Multi-Infarct Dementia Product Solution and Service Table 21. Date of Enter into Multi-Infarct Dementia Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 24. Global Multi-Infarct Dementia Revenue Market Share by Type (2016-2021) Table 25. Global Multi-Infarct Dementia Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Multi-Infarct Dementia Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Multi-Infarct Dementia Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Multi-Infarct Dementia Revenue Market Share by Application (2016-2021) Table 29. Global Multi-Infarct Dementia Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Multi-Infarct Dementia Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 32. North America Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million) Table 34. North America Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Multi-Infarct Dementia Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Multi-Infarct Dementia Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Multi-Infarct Dementia Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Multi-Infarct Dementia Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Multi-Infarct Dementia Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Multi-Infarct Dementia Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Multi-Infarct Dementia Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Multi-Infarct Dementia Market Size by Country (2022-2027) & (US$ Million) Table 61. Forest Laboratories Company Details Table 62. Forest Laboratories Business Overview Table 63. Forest Laboratories Multi-Infarct Dementia Product Table 64. Forest Laboratories Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 65. Forest Laboratories Recent Development Table 66. Janssen Pharmaceuticals Company Details Table 67. Janssen Pharmaceuticals Business Overview Table 68. Janssen Pharmaceuticals Multi-Infarct Dementia Product Table 69. Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 70. Janssen Pharmaceuticals Recent Development Table 71. Novartis Pharmaceutical Company Details Table 72. Novartis Pharmaceutical Business Overview Table 73. Novartis Pharmaceutical Multi-Infarct Dementia Product Table 74. Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 75. Novartis Pharmaceutical Recent Development Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Multi-Infarct Dementia Product Table 79. Pfizer Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 80. Pfizer Recent Development Table 81. Eisai Company Details Table 82. Eisai Business Overview Table 83. Eisai Multi-Infarct Dementia Product Table 84. Eisai Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 85. Eisai Recent Development Table 86. Ortho-McNeil Pharmaceutical Company Details Table 87. Ortho-McNeil Pharmaceutical Business Overview Table 88. Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Product Table 89. Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 90. Ortho-McNeil Pharmaceutical Recent Development Table 91. Takeda Company Details Table 92. Takeda Business Overview Table 93. Takeda Multi-Infarct Dementia Product Table 94. Takeda Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 95. Takeda Recent Development Table 96. Jubilant Cadista Pharmaceuticals Company Details Table 97. Jubilant Cadista Pharmaceuticals Business Overview Table 98. Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 99. Jubilant Cadista Pharmaceuticals Recent Development Table 100. Takeda Pharmaceutical Company Details Table 101. Takeda Pharmaceutical Business Overview Table 102. Takeda Pharmaceutical Multi-Infarct Dementia Product Table 103. Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2016-2021) & (US$ Million) Table 104. Takeda Pharmaceutical Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Multi-Infarct Dementia Market Share by Type: 2020 VS 2027 Figure 2. Pharmacological Treatment Features Figure 3. Non Pharmacological Treatment Features Figure 4. Global Multi-Infarct Dementia Market Share by Application: 2020 VS 2027 Figure 5. Academic Case Studies Figure 6. Hospitals Case Studies Figure 7. Other Case Studies Figure 8. Multi-Infarct Dementia Report Years Considered Figure 9. Global Multi-Infarct Dementia Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Multi-Infarct Dementia Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Multi-Infarct Dementia Market Share by Regions: 2020 VS 2027 Figure 12. Global Multi-Infarct Dementia Market Share by Regions (2022-2027) Figure 13. Global Multi-Infarct Dementia Market Share by Players in 2020 Figure 14. Global Top Multi-Infarct Dementia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multi-Infarct Dementia as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Multi-Infarct Dementia Revenue in 2020 Figure 16. Global Multi-Infarct Dementia Revenue Market Share by Type (2016-2021) Figure 17. Global Multi-Infarct Dementia Revenue Market Share by Type (2022-2027) Figure 18. North America Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Multi-Infarct Dementia Market Share by Type (2016-2027) Figure 20. North America Multi-Infarct Dementia Market Share by Application (2016-2027) Figure 21. North America Multi-Infarct Dementia Market Share by Country (2016-2027) Figure 22. United States Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Multi-Infarct Dementia Market Share by Type (2016-2027) Figure 26. Europe Multi-Infarct Dementia Market Share by Application (2016-2027) Figure 27. Europe Multi-Infarct Dementia Market Share by Country (2016-2027) Figure 28. Germany Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Multi-Infarct Dementia Market Share by Type (2016-2027) Figure 36. Asia-Pacific Multi-Infarct Dementia Market Share by Application (2016-2027) Figure 37. Asia-Pacific Multi-Infarct Dementia Market Share by Region (2016-2027) Figure 38. China Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Multi-Infarct Dementia Market Share by Type (2016-2027) Figure 46. Latin America Multi-Infarct Dementia Market Share by Application (2016-2027) Figure 47. Latin America Multi-Infarct Dementia Market Share by Country (2016-2027) Figure 48. Mexico Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Multi-Infarct Dementia Market Share by Type (2016-2027) Figure 52. Middle East & Africa Multi-Infarct Dementia Market Share by Application (2016-2027) Figure 53. Middle East & Africa Multi-Infarct Dementia Market Share by Country (2016-2027) Figure 54. Turkey Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Multi-Infarct Dementia Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Forest Laboratories Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 58. Janssen Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 59. Novartis Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 61. Eisai Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 62. Ortho-McNeil Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 63. Takeda Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 64. Jubilant Cadista Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Forest Laboratories Janssen Pharmaceuticals Novartis Pharmaceutical Pfizer Eisai Ortho-McNeil Pharmaceutical Takeda Jubilant Cadista Pharmaceuticals Takeda Pharmaceutical